Kristin Tweel excels at bridging science and business, specializing in communicating the value of science-based products and applications. With a PhD in Pharmacology from Dalhousie University and an MBA from Saint Mary’s University, she combines scientific expertise with business acumen to drive development, secure deals, and foster collaboration among diverse stakeholders.
Her experience includes working with BioVectra, where she developed models to assess risks and opportunities in generic drug development, reflecting her commitment to turning scientific knowledge into meaningful progress.